About Us | Contact Us |        

Achieving Optimal Outcomes for Patients with Rheumatoid Arthritis and Comorbid Conditions: A Team Approach

Title:

Achieving Optimal Outcomes for Patients with Rheumatoid Arthritis and Comorbid Conditions: A Team Approach

Topic: Rheumatology
Relevant Terms: Rheumatoid arthritis, arthritis, type 2 diabetes, heart failure, chronic pain, fibromyalgia
Primary Audience: Rheumatologists, Nurse Practitioners, Nurses, Physician Assistants, other healthcare providers who treat patients with RA
Launch Date: 17-May-16
Credits: AMA PRA Category 1 Credit
1 ANCC contact hour
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Achieving Optimal Outcomes in RA and Comorbid Conditions

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Articulate increased confidence in the identification of RA in patients with comorbid conditions
  2. Recognize which patients with RA and comorbid conditions are candidates for use of biological therapies
  3. Identify strategies to use in practice for providing interdisciplinary management of RA and comorbidities
  4. List the benefits and the safety risks of available and pending therapies for RA treatment  for patients with comorbid conditions
  5. Demonstrate increased competence in the ability to monitor patients with RA and comorbid conditions

    Faculty

    Tuhina Neogi, MD, PhD
    Associate Professor of Medicine
    Boston University School of Medicine
    Associate Professor of Epidemiology
    Boston University School of Public Health
    Boston, MA
    Jon T. Giles, MD, MPH
    Assistant Professor of Medicine
    Division of Rheumatology
    Columbia University, College of Physicians and Surgeons
    New York Presbyterian Hospital
    New York, NY
    Mark C. Fisher, MD, MPH
    Assistant Clinical Director
    Department of Rheumatology
    Massachusetts General Hospital
    Boston, MA
    Naomi Amudala, RN, FNP-BC
    Clinical Instructor and Nurse Practitioner
    Vasculitis Center/Rheumatology
    Boston University School of Medicine
    Boston, MA
    EDUCATIONAL NEEDS ADDRESSED
    Current literature indicates that rheumatologists are not providing optimal care when managing patients with RA. Practice gaps include: 1) variation in treatment; 2) lack of knowledge regarding safety issues and biologic treatment; 3) lack of knowledge and competence determining whether and when monotherapy or combination therapeutic treatment is suitable; 4) challenges in identifying the benefits and safety risks of available therapies including drug interactions.
     
    DISCLOSURE POLICY STATEMENT
    Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
     
    Faculty Disclosures
     
    Tuhina Neogi, MD, PhD
    CME Course Director
    Associate Professor of Medicine
    Boston University School of Medicine
    Dr. Neogi has no relevant financial relationships with commercial interest.
     
    Jon T. Giles, MD, MPH
    Assistant Professor of Medicine
    Division of Rheumatology
    Columbia University, College of Physicians and Surgeons
    New York Presbyterian Hospital
    Dr. Giles receives grant/research support from Genentech. He is a consultant for Pfizer and he sits on the board for Coherus.
     
    Mark Fisher, MD, MPH
    Assistant Clinical Director
    Department of Rheumatology
    Massachusetts General Hospital
    Dr. Fisher has no relevant relationships with commercial interests.
     
    Naomi Amudala, RN, FNP-BC
    CNE Course Advisor
    Clinical Instructor and Nurse Practitioner
    Vasculitis Center/Rheumatology
    Boston University School of Medicine
    Ms. Amudala has no relevant financial relationships with commercial interest.
     
    Planning Committee Disclosures
     
    Patti-Ann Collins, DNP, MSN/MBA, RN, Lead Nurse Planner, has no relevant financial relationships with any commercial interest.
    Elizabeth Drury, planner, has no relevant financial relationships with any commercial interest.
    Jody Walker, MS, planner, has no relevant financial relationships with any commercial interest.
    Julie White, MS, planner, has no relevant financial relationships with any commercial interest.
    Josh Kilbridge, medical writer, has no relevant financial relationships with any commercial interest
     
    Off-Label Discussions
    The faculty members do not plan on discussing any unlabeled/investigational uses of a commercial products.
     
    ACCREDITATION STATEMENTS
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Boston University School of Medicine designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    CNE Contact Hours: 1.0 all of which are eligible for Pharmacology credit.

    Nurses will receive contact hours after completion of the post test, evaluation and claim for credit form.
     
    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA category 1 credits™, and nurses are entitled to receive 1.00 CNE contact hours, all of which is pharmacology credit worthy. Statement of credit will be available to print from your user history page.
     
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians and nurses who successfully complete the post-test and evaluation will respectively receive CME or CNE. You must score with a 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
     
    Release Date: May 17, 2016
    Expiration Date: May 17, 2017
    Date of Most Recent Review: April 28, 2016
    Program Code: I.RA16a
     
    For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.
    To view Boston University’s Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.
    To view RealCME's Privacy Policy, please see http://www.healthcourse.com/privacy/.
     
    COMMERCIAL SUPPORT
    This activity is supported by an unrestricted educational grant from Pfizer.
     
    DISCLAIMER
    THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
     
     
     
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above